Landmark Bio Email Format

Biotechnology ResearchMassachusetts, United States51-200 Employees

Landmark Bio is a biotechnology research company based in Watertown, Massachusetts, specializing in cell and gene therapy manufacturing. It develops technologies, products, and services intended to bridge the gap from bench to patient and acts as a development partner for academic researchers, physician-scientists preparing IND filings, and biopharma leaders advancing pipelines. The company engages in viral vector process development, chemistry, manufacturing and controls (CMC), and GMP manufacturing, with collaborations and integrations such as with ChromaTan and NIIMBL-supported initiatives. Landmark Bio has undergone corporate changes, including an acquisition by OSR Holdings in 2023 and, in April 2025, acquisition by Artis BioSolutions, after which it operates as part of that organization. The organization employs 51-200 people and maintains its online presence at https://landmarkbio.com; reported revenue in the data ranges from $50 million to $100 million.

Sign up for free to view info

Company overview Employee directory